propranolol and insulin human

Propranolol is a non-selective beta-blocker. It blocks beta-2 adrenergic receptors, which mediate hepatic glycogenolysis and gluconeogenesis, thereby impairing the normal physiological counter-regulatory response to hypoglycaemia. Additionally, it masks the adrenergic symptoms of hypoglycaemia (such as tachycardia, palpitations, and tremor) that are mediated by beta-receptor stimulation. This combination of reduced glucose output and blunted warning signs leads to a decreased ability to recognise and recover from hypoglycaemia.

In patients receiving insulin, propranolol may mask the early warning signs of hypoglycaemia, such as tachycardia and tremor, making it difficult for the patient to recognise low blood glucose. Furthermore, it can delay the recovery from hypoglycaemia by blocking gluconeogenic mechanisms. Rarely, during a hypoglycaemic episode, unopposed alpha-adrenergic stimulation can cause paradoxical hypertension and bradycardia. These effects may lead to severe or prolonged hypoglycaemia, increasing the risk of neurological impairment or loss of consciousness.

Monitor blood glucose more frequently, especially when starting, stopping, or changing the dose of propranolol. Educate the patient about atypical symptoms of hypoglycaemia, such as sweating or a sense of weakness without tachycardia. Consider using a cardioselective beta-blocker (e.g., atenolol or metoprolol) which may be less likely to mask symptoms, though caution is still advised. Adjust insulin doses as necessary, and advise the patient to carry a source of fast-acting glucose. In high-risk patients, consider advising home glucose monitoring and carrying glucagon.

This interaction is well established in the literature, with numerous reports and authoritative guidelines. Beta-blockers are known to mask hypoglycaemic symptoms and impair recovery, and non-selective agents like propranolol are considered to have a greater effect than cardioselective agents. It is documented in standard drug interaction databases and clinical practice guidelines.